Approval · Notice of Compliance 13927 · 2012
PLIAGLIS: Notice of Compliance 13927
Issued December 6, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13927
- Date
- December 6, 2012
- Company
- Galderma Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Topical anesthetic for dermal analgesia
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PLIAGLIS | 02398028 | Marketed |
Medicinal ingredients
- LIDOCAINE 7 PER
- TETRACAINE 7 PER